Both in Pharmaceuticals
RenovoRx vs Aldeyra Therapeutics
Over the past year RNXT returned +33.1% and ALDX returned −74.7%; their daily moves had a correlation of 0.06.
RNXT +33.1% ALDX −74.7%Growth of $1, one year, split-adjusted
| Metric | RNXT | ALDX |
|---|---|---|
| Price | $1.57 | $1.32 |
| Market cap | $70.9M | $79.6M |
| Today | +1.29% | +13.79% |
| 1 month | −6.0% | −11.1% |
| 6 months | +46.7% | −21.4% |
| Year to date | +86.9% | −74.5% |
| 1 year | +33.1% | −74.0% |
| Revenue growth (YoY) | +115.4% | — |
| Gross margin | 84.3% | — |
| Net margin | −320.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 35.9× | — |
| Net cash | $9.5M | $45.1M |
| Dividend yield | — | — |
| Volatility (60d) | 107.0% | 69.9% |
| Short % of float | 1.6% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).